Mucopolysaccharidosis II

Overview

Systemic lysosomal storage disease marked by progressive physical deterioration and caused by a deficiency of L-sulfoiduronate sulfatase. This disease differs from MUCOPOLYSACCHARIDOSIS I by slower progression, lack of corneal clouding, and X-linked rather than autosomal recessive inheritance. The mild form produces near-normal intelligence and life span. The severe form usually causes death by age 15.

This information is general and should not be treated as medical advice. Always speak directly with a qualified healthcare professional before making decisions about treatment, diagnosis, procedures, medicines or care.

Quick facts about Mucopolysaccharidosis II

Topic type

Condition

Category

Dermatology

MeSH classification

C10.597.606.360.455.750|C16.320.322.500.750|C16.320.400.525.750|C16.320.565.202.715.645|C16.320.565.595.600.645|C17.300.550.575.645|C18.452.648.202.715.645|C18.452.648.595.600.645

Preparing for an appointment about Mucopolysaccharidosis II

If you are speaking with a healthcare professional about Mucopolysaccharidosis II, it can help to prepare a few details in advance.

• Write down your symptoms and when they started.
• Bring details of any medicines, supplements or previous treatments.
• Ask what tests or assessments may be needed.
• Ask what treatment or management options may be suitable.
• Ask when you should seek urgent medical help or follow-up care.

Finding care related to Mucopolysaccharidosis II

EuroCareFinder helps patients explore clinics and healthcare providers across Europe. Some topics link directly to services offered by clinics, while others may be connected through related specialties, treatments or procedures.

Related topics

Explore healthcare providers

Use EuroCareFinder to browse clinics by country, specialty and available services.